EGFR and ovarian carcinoma: To determine if our targeted delivery of EGFR siRNA to ovarian cancer cells could be used to increase cell line sensitivity to taxanes, Hey cells were incubated with EGFR siRNA-loaded nanogels for 48 hours to allow for maximum reduction in EGFR expression (see Figures 2A and 2B).